Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.

Crystalline nephropathy Monoclonal gammopathy RACE-RepSeq immunoglobulin repertoire sequencing membranous nephropathy multiple myeloma

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
22 Jan 2024
Historique:
received: 17 07 2023
revised: 10 10 2023
accepted: 15 11 2023
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 24 1 2024
Statut: aheadofprint

Résumé

Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as intracellular or extracellular crystals. We describe a patient with multiple myeloma (IgGλ) and diabetes who presented with nephrotic range proteinuria. Kidney biopsy revealed membranous nephropathy superimposed on diabetic glomerulosclerosis. Glomeruli were negative for PLA2R, THSD7A, and NELL-1. Ultrastructurally, the subepithelial deposits were composed of crystals (ranging from rhomboid to rod to needle shaped), which failed to stain for immunoglobulins by routine immunofluorescence but stained for IgG + λ by paraffin immunofluorescence after pronase digestion. RNA-based immunoglobulin repertoire sequencing performed on bone marrow aspirate identified an IgGλ (γ1) clone which was highly atypical, combining an extensively mutated (23.6%) Ig heavy chain derived from the IGHV1-24 with low pI and unusual mutations and a light chain derived from an extremely rare germline gene (IGLV10-54). This report expands the pathologic spectrum of MIg crystalline nephropathies by describing a unique case of crystalline nephropathy with IgGλ deposits manifesting as membranous nephropathy.

Identifiants

pubmed: 38266972
pii: S0272-6386(24)00041-6
doi: 10.1053/j.ajkd.2023.11.011
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Salvatore E Mignano (SE)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Virginie Pascal (V)

Department of Immunology and Immunogenetics, Centre Hospitalier Universitaire de Limoges, Limoges, France; Control of the immune response B and lymphoproliferation, CNRS UMR 7276, INSERM UMR 1262, University of Limoges, Centre de référence de l'amylose AL et autres maladies par dépôts d'immunoglobuline monoclonale, Limoges, France.

Nnaemezie E Odioemene (NE)

Cobb Nephrology Hypertension Associates, PC, Austell, GA, USA.

William Forehand (W)

Northwest Georgia Oncology Centers Wellstar, Hiram, GA, USA.

Vincent Javaugue (V)

Control of the immune response B and lymphoproliferation, CNRS UMR 7276, INSERM UMR 1262, University of Limoges, Centre de référence de l'amylose AL et autres maladies par dépôts d'immunoglobuline monoclonale, Limoges, France; Service de néphrologie et Centre National de référence amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, France.

Samar M Said (SM)

Department of Pathology, Olmsted County Medical Center, Rochester, MN, USA.

Sanjeev Sethi (S)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Christophe Sirac (C)

Control of the immune response B and lymphoproliferation, CNRS UMR 7276, INSERM UMR 1262, University of Limoges, Centre de référence de l'amylose AL et autres maladies par dépôts d'immunoglobuline monoclonale, Limoges, France. Electronic address: christophe.sirac@unilim.fr.

Samih H Nasr (SH)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: Nasr.samih@mayo.edu.

Classifications MeSH